I know that sounds like a stupid question, but I have been to 18 doctors (19 as of tomorrow) in the past 2 years!! I am 17 years old, and have many of the Lyme symptoms...had the bulls eye rash, etc. My mom is concerned that if we go to an LLMD and it's not Lyme, then we will have forked out another few hundred dollars for nothing. Does anyone know how that works?
Frequent Contributor (1K+ posts)
Member # 2321
If you had a bull's eye rash it's lyme. A bulls eye rash is diagnostic for lyme.
You might have infections in addition to lyme. For one, some subspecies of lyme compromise the immune system by attacking B-cells. For 2 many ticks carry more than one infection. In some areas bartonella is the most common co-infection. Most LLMDs consider and have experience with multiple infections.
You might save money by asking the LLMD how much experience he or she has in treating co-infections.
Posts: 1436 | From Humboldt county ca usa | Registered: Mar 2002
| IP: Logged |
Honored Contributor (25K+ posts)
Member # 12673
If you had the bullseye rash, that is a unique marker to lyme.
If you can, please keep the appointment with the LLMD.
It will save you money in the long-run - and might save your life.
From what you say and what I've studied, gettting evaluated by an LLMD is vital. As stated in post above, it's not just lyme. You need to be evaluated for varous tick-borne infections. Only a LLMD can take your history, and know how to proceed.
And, again, the bullseye rash is a clear sign of lyme all by itself. If you have a photo of that it may be helpful. If you have a list of the anti-biotics you've been on and a time-line that would be helpful, too.
Did you get any treatment at the time of the rash? If not, how long . . ? Having these answers will make the appt. go faster.
I know this is a hard decision for you and for your family so I wish you all the best of luck.
In general LLMDs should be able to help you with other illnesses besides Lyme. LLMDs make up a broad range of specialties. Some are internal medicine docs, others family medicine and others are infectious disease doctors etc.
If you have an issue that's not related to Lyme, but let's say it's a neurological issue, then you would be better off seeing a neurologist. If your LLMD happens to be a neurologist, then you won't have to go elsewhere.
If you go to the AMA website, you can look up your doctor and it'll tell you what he/she specializes in.
Did any of the doctors you saw ever diagnose you with Lyme? The bullseye rash is indicative of Lyme. Lyme should have at least been considered in your case.
-------------------- The best index to a person's character is how he treats people who can't do him any good, and how he treats people who can't fight back. -Abigail van Buren (Pauline Esther Friedman) (1918-2002) Posts: 409 | From Florida | Registered: Dec 2005
| IP: Logged |
Frequent Contributor (1K+ posts)
Member # 5374
I know you've been to many doctors and it has been a large expense. But this is a question to pose to your mother. If it was possible that you had cancer, would your mother decide not to take you to an oncologist because an oncologist wouldn't treat you if it turned out you don't have cancer?
My guess is, no. Your mother would want you to see the best oncologist possible.
If you have had a bulls eye rash, then you need to consider Lyme disease. No other doctor but an LLMD has the knowledge you need.
-------------------- "When there is pain, there are no words." - Toni Morrison Posts: 4711 | From Washington, DC | Registered: Mar 2004
| IP: Logged |
DocDave (stymielymie) posted about what doctor's are taught about diagnosis, ANY good doctor should do a differential diagnosis. Until my LLMD, I had never had a doctor do a differential diagnosis!
My LLMD tested me for everything, and is treating me for things that are not Lyme -- heavy metals and bacterial dysbiosis.
My daughter had about 13 vials of blood drawn to test her for everything to see what was going on with her. I can't imagine how many doctors I would have had to take her for to get all those tests done, yet my LLMD did it all at the first appt.
-------------------- sixgoofykids.blogspot.com Posts: 13449 | From Ohio | Registered: Feb 2007
| IP: Logged |
A bulls-eye rash IS Lyme disease, is diagnostic for Lyme disease. LLMDs are great for other things besides Lyme in my experience and will be able to help you because you HAVE Lyme if you had a bulls-eye rash.
-------------------- There is no wealth but life. -John Ruskin
All truth goes through 3 stages: first it is ridiculed: then it is violently opposed: finally it is accepted as self evident. - Schopenhauer Posts: 5639 | From Aptos CA USA | Registered: Apr 2005
| IP: Logged |
Your life depends on you seeing an LLMD! If you had the Bullseye
rash, you were exposed to Lyme, and if you weren't treated
extremely aggressively (with SEVERAL antibiotics it high doses)
soon after exposure, you still have it. I am 18, and have had this
disease since early May. My relationship with my parents has been
greatly strained due to the fact that they are not receptive to the
information about this horrific disease I broach to them, I live in
constant physical pain (in the form of an unremitting headache),
and am losing to dementia a huge part of what makes my life
worthwhile. With treatment begun soon there is hope; without,
only a fate many consider worse than death.
Oh, and just to assauge your mom's fears if by chance she, like
mine, can't be convinced by any means you have Lyme,--
Yes, a good LLMD will do a VERY thorough evaluation of you and
has at least as good a chance as any other doc of finding any
I had a severe headpain/headache as well. It's better now.
You might look at the library for a copy of Coping With Lyme Disease, by Denise Lang, and give it to your parents to read. Show them the signs and symptoms pages and give them a list of your signs and symptoms, to compare.
And show them the ILADS site under "Treatment Guidelines," Dr. Burrascano's 33 pages of tips for 2005; also the ILADS Guidelines. Maybe you already have.
Have you contacted a support group in Minnesota? At the top of this page on the left, find support groups to find a Minnesota group. I'm from Minnesota, originally. Tell you're folks that Minnesota is one of the most Lyme endemic areas of the country.
I've been aware of you, adammm. I've been reading some of your posts. We're here for you.
Knshore: Yes, a bullseye rash along with signs and symptoms is certainly Lyme disease. I Know you're scared. Perhaps the above paragraphs to Adamm will help.
Important to know: Doctors know about Lyme. However, if they talk seriously about it with patients, they very much risk being ridiculed by their fellow doctors. And they may feel their job is threatened by your insurance company, if they talk seriously about it.
There is a battle going on between IDSA (Infectious Disease Society of America) and ILADS (International Lyme and Associated disease society.)
On the part of IDSA, which denies Lyme, it is a battle of big money and politics. On the part of the ILADS physicians it is a battle to help hurting, very ill patients with Lyme and other diseases from ticks.
The Connecticut Attorney General has filed legal action against IDSA.
Chronic Lyme disease is disabling and the body can't possibly clear it without high dose, prolonged multiple antibiotics. That absolutely requires a lyme-literate doctor (LLMD.)
I'm sorry you have Lyme disease, knshore.
To Adamm and knshore: Nearly all of us know the financial burden inherent with Lyme. There is a lot of help at this website on dealing with insurance companies and the financial burden.
Some of it may have already been mailed to you. You and your folks must find a way, together, to get a good LLMD for both you.
If the tiny URL does not connect, try a little later, or search title through home page at www.clinicaladvisor.com ----------
Illustrations, charts can be viewed at the link
The Clinical Advisor is a monthly journal for nurse practitioners and physician assistants in primary care.
From the May 2007 issue of Clinical Advisor
Controversy continues to fuel the ``Lyme War'' By Virginia Savely, RN, FNP-C
As two medical societies battle over its diagnosis and treatment, Lyme disease remains a frequently missed illness. Here is how to spot and treat it.
Controversy over the treatment of a particular disease is not uncommon. There are many illnesses for which there are different schools of thought and more than one treatment method--e.g., heart disease, prostate cancer, and breast cancer. When it comes to Lyme disease, a bacterial infection caused by the corkscrew-shaped spirochete ,Borrelia burgdorferi, the battle lines are particularly distinct, and the opposing viewpoints reach vitriolic proportions, to the ultimate detriment of the patients.
Lyme disease, which is most commonly acquired through the bite of an infected tick, has been reported in every state and has become the most common vectorborne disease in the United States
. In 2005, the CDC received reports of 23,305 cases, resulting in a national average of 7.9 cases for every 100,000 persons.
In the 10 states where the infection is most common, the average was 31.6 cases for every 100,000 persons. The CDC estimates that the disease is grossly underreported, probably by a factor of 10.
Meet the players ****************
The opponents in the battle over the diagnosis and treatment of Lyme disease are the Infectious Diseases Society of America (IDSA), the largest national organization of general infectious disease specialists, and
the International Lyme and Associated Diseases Society (ILADS), an organization made up of physicians from many specialties.
IDSA maintains that Lyme disease is relatively rare, overdiagnosed, difficult to contract, easy to diagnose through blood testing, and straightforward to treat (www.journals.uchicago.edu/CID/journal/issues/v43n9/40897/40897.html. Accessed April 6, 2007).
ILADS, by contrast, asserts that the illness is much more common than reported, underdiagnosed, easier to contract than previously believed, difficult to diagnose through commercial blood tests, and difficult to treat, especially when treatment is delayed because of commonly encountered diagnostic difficulties (www.ilads.org /guidelines.html. Accessed April 6, 2007).
Diagnosis: Where it all begins *****************************
If all cases were detected and treated in the early stages of Lyme disease, the debate over the diagnosis and treatment of late-stage disease would not be an issue, and devastating rheumatologic, neurologic, and cardiac complications could be avoided. However, Lyme disease is often missed during its early stage when it could be most easily treated (Table 1).
Since the deer tick is no larger than the period at the end of this sentence, it is not surprising that people frequently do not realize they've been bitten. In a hairy part of the body, the tick is almost impossible to see, and even when it is noticed, it is often mistaken for a mole or scab.
When the tick latches on, it injects salivary components that anesthetize the area and decrease inflammation at the site of the bite, leaving the victim unaware of the tick's presence and allowing it to feast undisturbed.
The erythema migrans (EM) rash is commonly known as the ``bull's-eye'' rash for its characteristic shape.
The CDC maintains that a patient presenting with a bull's-eye rash does NOT require testing for Lyme disease because the rash is diagnostic in its own right.
However, the rash does not always present in the classic pattern of concentric, round, red circles. EMs can be oval in shape and/or solid in color, with shades of pink, purple, and red.
The rash may or may not contain pustules, itch, feature a dark spot in the middle, or have a denuded center. The size varies from that of a quarter to 12 in or more.
Some victims develop a diffuse rash over the entire body. EMs are commonly misdiagnosed as spider bites, cellulitis, or ringworm. To complicate matters further, as many as half the people who acquire Lyme disease from a tick bite develop NO RASH at all.
Frequently, a clinician mistakenly assumes that there are no Borrelia-carrying ticks in the patient's geographic area and fails to include the disease in the appropriate differential diagnosis. Lyme disease should be considered regardless of where a patient lives.
Ticks are carried on numerous animals, including household pets, rodents, deer, and birds, so it is little wonder that Lyme disease-transmitting ticks are not confined to a few distinct geographic areas.
A travel history should be obtained to determine whether the patient has recently traveled to a particularly Lyme-endemic area (the northeastern United States, north-central United States, and the Pacific coastal region).
Most clinicians are not familiar with the varied signs and symptoms of Lyme disease (Table 2), and this contributes to misdiagnosis (Table 3).
Children may present differently than adults, with predominant symptoms being changes in behavior and school performance.
In affected children, parents typically report mood swings, irritability, obsessive-compulsive behavior, and new-onset attention-deficit/hyperactivity disorder. Physical symptoms in children may include fatigue, frequent headaches or stomachaches, urinary symptoms, and migratory musculoskeletal pains.
When a patient presents with a collage of seemingly unrelated symptoms, there is a natural tendency to assume that a psychological component is at play. Patients with Lyme disease almost always have negative results on standard blood screening tests and have no remarkable findings on physical exam, so they are frequently referred to mental-health professionals for evaluation.
The testing conundrum *********************
The CDC is aware of the insensitivity of the tests for Lyme disease and encourages clinicians to use judgment rather than a test result to make the diagnosis (www.cdc.gov/ncidod/dvbid /lyme/ld_humandisease_diagnosis.htm. Accessed April 5, 2007).
As previously mentioned, however, most clinicians do not feel confident in making this judgment call and continue to look to unreliable test results for confirmation of disease.
The Western blot test **********************
Because B. burgdorferi is an extremely difficult bacterium to culture in the lab, testing has relied on detection of antibodies to the organism. The Lyme enzyme-linked immunosorbent assay (ELISA) gives a titer of total immunoglobulin (Ig) G and M antibodies and is currently the accepted initial screen for suspected disease.
Since a screening test should have at least 90% sensitivity, the 65% sensitivity of the commercial Lyme ELISA should lead to its reconsideration as an acceptable screening tool .
The Western blot, which is commonly used as a confirmatory test for Lyme disease, is more sensitive than the ELISA.
While the CDC has published strict criteria for positivity on the Western blot to make a more exclusive cohort for epidemiologic purposes, it never intended for these criteria to be used for diagnosis. Unfortunately, the restrictive criteria omit several of the important bands on the blot that are highly sensitive markers for the presence of B. burgdorferi (see ``Interpreting the Western blot,'').
Clinicians should become acquainted with the relative sensitivity and specificity of each of the bands on the blot to make an appropriate assessment for diagnostic purposes.
A negative test based on epidemiologic criteria may be a positive test for diagnostic purposes.
Treatment dilemmas ******************
The Lyme spirochete presents a formidable adversary. With more than 1,500 gene sequences, B. burgdorferi is genetically one of the most sophisticated bacteria ever studied.
Treponema pallidum (the spirochete responsible for syphilis), for example, has 22 functioning genes whereas the Lyme disease spirochete has 132.
Borrelia burgdorferi's stealth pathology makes eradication of the disseminated organism a near impossibility.
Before the tick delivers its inoculum of spirochetes into the host, it injects a substance that inhibits the immune response, allowing the spirochete to gain a strong foothold. The spirochete itself secretes enzymes that help it to replicate and infect the host.
Once disseminated throughout the body, B. burgdorferi secludes itself and becomes difficult to detect through laboratory testing--and by the host's immune system. The bacterium may hide in its host's WBCs or cloak itself with host proteins.
Furthermore, it tends to hide in areas not usually under immune surveillance, such as scar tissue, the central nervous system, the eyes, and deep in joints and other tissues.
Phase and antigenic variations allow B. burgdorferi to change into pleomorphic forms to evade the immune system and antibiotics.
The three known forms are the spiral shape that has a cell wall, the cell-wall-deficient form known as the ``L-form'' (named not for its shape but for Joseph Lister, the scientist who first identified these types of cells), and the dormant or latent cyst form.
Encapsulating itself into the inactive cyst form enables the spirochete to hide undetected in the host for months, years, or decades until some form of immune suppression initiates a signal that it is safe for the cysts to open and the spirochetes to come forth and multiply .
Each of these forms is affected by different types of antibiotics. If an antibiotic targets the bacterium's cell wall, the spirochete will quickly morph into a cell-wall-deficient form or cyst form to evade the chemical enemy.
Borrelia burgdorferi has an in vitro replication cycle of about seven days, one of the longest of any known bacteria.
Antibiotics are most effective during bacterial replication, so the more cycles during a treatment, the better.
Since the life cycle of Streptococcus pyogenes (the bacterium that causes strep throat) is about eight hours, antibiotic treatment for a standard 10 days would cover 30 life cycles.
To treat Lyme disease for a comparable number of life cycles, treatment would need to last 30 weeks.
Within the tick gut are hundreds of different types of pathogens. How many infect humans is unknown.
Some have been identified and are known to intensify morbidity and complicate treatment of Lyme disease.
Awareness of three coinfecting genuses in particular--Ehrlichia, Bartonella, and Babesia--has increased, and persistent infection with these organisms has been described.
Testing for and treating these coinfections has become part of the approach for clinicians who specialize in the treatment of Lyme disease.
Treatment methods *****************
IDSA guidelines recommend treating certain high-risk tick bites with a prophylactic single dose of doxycycline. This is recommended only if the tick is clearly a deer tick that was attached for 36 hours or more, the patient was in an endemic area, and if treatment can be started within 72 hours of the time the tick was removed.
Most ILADS practitioners treat any high-risk tick bite with a full month of doxycycline.
If a patient presents with EM or has a positive Lyme test, IDSA guidelines recommend treating with either doxycycline, cefuroxime, or amoxicillin for 10-21 days.
All other antibiotics are specifically not recommended. After the prescribed amount of time, treatment is discontinued whether symptoms remain or not.
However, if symptoms remain severe after the patient has been off the antibiotics for a few months, treatment with another two to four weeks can be considered. One month of IV antibiotics is recommended for severe arthritis or neurologic disease.
IDSA stresses that persistent symptoms do NOT indicate chronic infection and that prescribing long-term antibiotics to patients unresponsive to the typical two- to four-week course is USELESS and potentially harmful.
``There is no convincing biologic evidence for the existence of symptomatic chronic B. burgdorferi infection among patients after receipt of recommended treatment regimens for Lyme disease,'' the guidelines state.
``Antibiotic therapy has not proven to be useful and is not recommended for patients with chronic (six months or longer) subjective symptoms after recommended treatment regimens for Lyme disease.''
Patients who continue to suffer from persistent fatigue, pain, and cognitive disturbances after a traditional short course of antibiotics are rare, the IDSA panel claims.
These patients have developed ``post-Lyme syndrome,'' probably due to an immune system that cannot shut down after the infection is gone. This syndrome can only be treated with symptomatic care and tincture of time.
ILADS, on the other hand, promotes the idea that the Lyme spirochete is very hard to eradicate and persistent symptoms are due to ongoing infection.
This organization's approach is to treat with antibiotics as long as symptoms remain. Off-label combinations are often used based on clinical experience.
Variable response to antibiotics and occasional antibiotic resistance are thought due to the fact that there are over 100 strains of B. burgdorferi in the United States and 300 strains worldwide .
Since the Lyme spirochete is adaptive and morphs to a new cell type when under stress, clinicians who advocate aggressive, long-term treatment support giving two or three different classes of antibiotics at the same time and changing the treatment protocol every two to three months.
Higher-than-normal doses of antibiotics are given to achieve better penetration of both the tissue and the blood-brain barrier.
IM injections of long-acting penicillin or IV administration of antibiotics are recommended for patients with neurologic disease.
Precedent for the safety of long-term antibiotic use has shown that the benefits outweigh the risks.
According to ILADS, treatment is complicated by the frequent presence of coinfections, which can intensify symptoms and prolong treatment.
Therefore, antibiotics that target the coinfections are usually prescribed prior to or along with those that treat Lyme disease.
Table 4 lists treatment options used by ILADS clinicians to target the various forms of the B. burgdorferi bacterium, and Table 5 lists treatment options for the most common coinfections.
Occasionally, Jarisch-Herxheimer reactions complicate Lyme disease treatment. These symptom intensifications are due to elevated cytokines and toxins released during B. burgdorferi die-off.
Many patients notice that symptoms occur cyclically (every 21-28 days). When these intensification reactions occur, the treatment can be temporarily worse than the disease.
It is difficult to decide when to stop treating Lyme disease since there is no test that demonstrates a cure.
Because of the lack of simple culture techniques and the low sensitivity of antibody tests, a negative test does not rule out infection.
Treatment cessation is based on symptom resolution, which means that symptoms may return if the infection has not been eradicated.
The road ahead **************
Rather than shy away from the complexities and controversies of Lyme disease, clinicians should welcome the chance to learn about this condition. Lyme disease is much more prevalent than most realize. Clinician education will reduce patient suffering and hopefully put an end to the ``Lyme War.''
For a list of references used in this article, contact the editor via e-mail ([email protected]) or telephone (646.638.6077).
Ms. Savely is the owner of TBD Medical Associates in San Francisco. She is a nurse practitioner who specializes in treatment of Lyme disease and other tickborne illnesses.